Biomimetic gold nanocomplexes for gene knockdown: Will gold deliver dividends for small interfering RNA nanomedicines?

Nano Research

Volumn 8, Issue 10, 2015, Pages 3111-3140

  Guo, Jianfeng ^a   Rahme, Kamil ^b,c,d   Fitzgerald, Kathleen A ^a   Holmes, Justin D ^c,d   O’Driscoll, Caitriona M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b NOTRE DAME UNIVERSITY   (Lebanon)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

multifunctional nanoparticles; nanotoxicity of gold nanoparticles; RNA interference (RNAi) based therapeutics; siRNA delivery

Indexed keywords

EID: 84943364330     PISSN: 19980124     EISSN: 19980000     Source Type: Journal    
DOI: 10.1007/s12274-015-0829-4     Document Type: Review

References (199)

1. Kanasty, R.; Dorkin, J. R.; Vegas, A.; Anderson, D. Delivery materials for siRNA therapeutics. Nat. Mater. 2013, 12, 967–977.
2. Guo, J.; Bourre, L.; Soden, D. M.; O’Sullivan, G. C.; O’Driscoll, C. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics? Biotechnol. Adv. 2011, 29, 402–417.
3. Mohseni, M.; Sun, J.; Lau, A.; Curtis, S.; Goldsmith, J.; Fox, V. L.; Wei, C.; Frazier, M.; Samson, O.; Wong, K. K.; Kim, C.; Camargo, F. D. A genetic screen identifies an LKB1- MARK signalling axis controlling the Hippo-YAP pathway. Nat. Cell Biol. 2014, 16, 108–117.
4. Schramek, D.; Sendoel, A.; Segal, J. P.; Beronja, S.; Heller, E.; Oristian, D.; Reva, B.; Fuchs, E. Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas. Science2014, 343, 309–313.
5. Guo, J. F.; Cahill, M. R.; McKenna, S. L.; O'Driscoll, C. M. Biomimetic nanoparticles for siRNA delivery in the treatment of leukaemia. Biotechnol. Adv. 2014, 32, 1396–1409.
6. Strumberg, D.; Schultheis, B.; Traugott, U.; Vank, C.; Santel, A.; Keil, O.; Giese, K.; Kaufmann, J.; Drevs, J. Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors. Int. J. Clin. Pharmacol. Ther. 2012, 50, 76–78.
7. Tabernero, J.; Shapiro, G. I.; LoRusso, P. M.; Cervantes, A.; Schwartz, G. K.; Weiss, G. J.; Paz-Ares, L.; Cho, D. C.; Infante, J. R.; Alsina, M. et al. First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. Cancer Discov. 2013, 3, 406–417.
8. Williford, J. M.; Wu, J.; Ren, Y.; Archang, M. M.; Leong, K. W.; Mao, H. Q. Recent advances in nanoparticle-mediated siRNA delivery. Annu. Rev. Biomed. Eng. 2014, 16, 347–370.
9. Giacca, M.; Zacchigna, S. Virus-mediated gene delivery for human gene therapy. J. Control. Release2012, 161, 377–388.
10. Waehler, R.; Russell, S. J.; Curiel, D. T. Engineering targeted viral vectors for gene therapy. Nat. Rev. Genet. 2007, 8, 573–587.
11. Ginn, S. L.; Alexander, I. E.; Edelstein, M. L.; Abedi, M. R.; Wixon, J. Gene therapy clinical trials worldwide to 2012- an update. J. Gene. Med. 2013, 15, 65–77.
12. Cobley, C. M.; Chen, J.; Cho, E. C.; Wang, L. V.; Xia, Y. Gold nanostructures: A class of multifunctional materials for biomedical applications. Chem. Soc. Rev. 2011, 40, 44–56.
13. Wen, S.; Li, K.; Cai, H.; Chen, Q.; Shen, M.; Huang, Y.; Peng, C.; Hou, W.; Zhu, M.; Zhang, G. et al. Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/ MR imaging applications. Biomaterials2013, 34, 1570–1580.
14. Barhate, G.; Gautam, M.; Gairola, S.; Jadhav, S.; Pokharkar, V. Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: Stability and immunoefficiency studies. Int. J. Pharm. 2013, 441, 636–642.
15. Okuno, T.; Kato, S.; Hatakeyama, Y.; Okajima, J.; Maruyama, S.; Sakamoto, M.; Mori, S.; Kodama, T. Photothermal therapy of tumors in lymph nodes using gold nanorods and near-infrared laser light. J. Control. Release2013, 172, 879–884.
16. Jing, L.; Liang, X.; Deng, Z.; Feng, S.; Li, X.; Huang, M.; Li, C.; Dai, Z. Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer. Biomaterials2014, 35, 5814–5821.
17. Huang, P.; Pandoli, O.; Wang, X. S.; Wang, Z.; Li, Z. M.; Zhang, C. L.; Chen, F.; Lin, J.; Cui, D. X.; Chen, X. Y. Chiral guanosine 5’-monophosphate-capped gold nanoflowers: Controllable synthesis, characterization, surface-enhanced Raman scattering activity, cellular imaging and photothermal therapy. Nano Res. 2012, 5, 630–639.
18. Kim, D. W.; Kim, J. H.; Park, M.; Yeom, J. H.; Go, H.; Kim, S.; Han, M. S.; Lee, K.; Bae, J. Modulation of biological processes in the nucleus by delivery of DNA oligonucleotides conjugated with gold nanoparticles. Biomaterials2011, 32, 2593–2604.
19. Bao, Q. Y.; Geng, D. D.; Xue, J. W.; Zhou, G.; Gu, S. Y.; Ding, Y.; Zhang, C. Glutathione-mediated drug release from Tiopronin-conjugated gold nanoparticles for acute liver injury therapy. Int. J. Pharm. 2013, 446, 112–118.
20. Ding, Y.; Zhou, Y. Y.; Chen, H.; Geng, D. D.; Wu, D. Y.; Hong, J.; Shen, W. B.; Hang, T. J.; Zhang, C. The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles. Biomaterials2013, 34, 10217–10227.
21. Monem, A. S.; Elbialy, N.; Mohamed, N. Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemophotothermal therapy. Int. J. Pharm. 2014, 470, 1–7.
22. Bao, C.; Conde, J.; Polo, E.; del Pino, P.; Moros, M.; Baptista, P. V.; Grazu, V.; Cui, D.; de la Fuente, J. M. A promising road with challenges: Where are gold nanoparticles in translational research? Nanomedicine (Lond)2014, 9, 2353–2570.
23. Daniel, M. C.; Astruc, D. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 2004, 104, 293–346.
24. Link, S.; EI-Sayed, M. A. Size and temperature dependence of the plasmon absorption of colloidal gold nanoparticles. J. Phys. Chem. B1999, 103, 4212–4217.
25. Sperling, R. A.; Rivera Gil, P.; Zhang, F.; Zanella, M.; Parak, W. J. Biological applications of gold nanoparticles. Chem. Soc. Rev. 2008, 37, 1896–1908.
26. Huang, X.; Jain, P. K.; El-Sayed, I. H.; El-Sayed, M. A. Gold nanoparticles: Interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond)2007, 2, 681–693.
27. Dreaden, E. C.; Alkilany, A. M.; Huang, X.; Murphy, C. J.; El-Sayed, M. A. The golden age: Gold nanoparticles for biomedicine. Chem. Soc. Rev. 2012, 41, 2740–2779.
28. Murphy, C. J.; Sau, T. K.; Gole, A. M.; Orendorff, C. J.; Gao, J.; Gou, L.; Hunyadi, S. E.; Li, T. Anisotropic metal nanoparticles: Synthesis, assembly, and optical applications. J. Phys. Chem. B2005, 109, 13857–13870.
29. Orendorff, C. J.; Sau, T. K.; Murphy, C. J. Shape-dependent plasmon-resonant gold nanoparticles. Small2006, 2, 636–639.
30. Rahme, K.; Gauffre, F.; Marty, J. D.; Payre, B.; Mingotaud, C. A systematic study of the stabilization in water of gold nanoparticles by poly(ethylene oxide)-poly(propylene oxide)- poly(ethylene oxide) triblock copolymers. J. Phys. Chem. C2007, 111, 7273–7279.
31. Kelly, K. L.; Coronado, E.; Zhao, L. L.; Schatz, G. C. The optical properties of metal nanoparticles: The influence of size, shape, and dielectric environment. J. Phys. Chem. B2003, 107, 668–677.
32. Niu, J.; Zhu, T.; Liu, Z. One-step seed-mediated growth of 30–150 nm quasispherical gold nanoparticles with 2-mercaptosuccinic acid as a new reducing agent. Nanotechnology2007, 18, 325607.
33. Perrault, S. D.; Chan, W. C. Synthesis and surface modification of highly monodispersed, spherical gold nanoparticles of 50–200 nm. J. Am. Chem. Soc. 2009, 131, 17042–17043.
34. Huang, Y.; Kim, D. H. Synthesis and self-assembly of highly monodispersed quasispherical gold nanoparticles. Langmuir2011, 27, 13861–13867.
35. Rahme, K.; Chen, L.; Hobbs, R. G.; Morris, M. A.; O’Driscoll, C.; Holmes, J. D. PEGylated gold nanoparticles: Polymer quantification as a function of PEG lengths and nanoparticle dimensions. RSC Adv. 2013, 3, 6085–6094.
36. Cai, W.; Gao, T.; Hong, H.; Sun, J. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol. Sci. Appl. 2008, 2008, 17–32.
37. +-cetyltrimethylammonium bromide solution: A novel precursor for seed-mediated growth of gold nanoparticles in aqueous solution. Nano Res. 2013, 6, 29–37.
38. Abdelhalim, M. A. K.; Mady, M. M.; Ghannam, M. M. Physical properties of different gold nanoparticles: Ultravioletvisible and fluorescence measurements. J. Nanomed. Nanotechnol. 2012, 3, 1000133.
39. Eustis, S.; EI-Sayed, M. A. Why gold nanoparticles are more precious than pretty gold: Noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes. Chem. Soc. Rev. 2006, 35, 209–217.
40. Hohenau, A.; Krenn, J. R.; Schider, G.; Ditlbacher, H.; Leitner, A.; Aussenegg, F. R.; Schaich, W. L. Optical nearfield of multipolar plasmons of rod-shaped gold nanoparticles. Europhys. Lett. 2005, 69, 538–543.
41. Link, S.; EI-Sayed, M. A. Spectral properties and relaxation dynamics of surface plasmon electronic oscillations in gold and silver nanodots and nanorods. J. Phys. Chem. B1999, 103, 8410–8426.
42. Sau, T. K.; Murphy, C. J. Room temperature, high-yield synthesis of multiple shapes of gold nanoparticles in aqueous solution. J. Am. Chem. Soc. 2004, 126, 8648–8649.
43. Hao, E.; Bailey, R. C.; Schatz, G. C.; Hupp, J. T.; Li, S. Synthesis and optical properties of “branched” gold nanocrystals. Nano Lett. 2004, 4, 327–330.
44. Murphy, C. J.; Gole, A. M.; Hunyadi, S. E.; Orendorff, C. J. One-dimensional colloidal gold and silver nanostructures. Inorg. Chem. 2006, 45, 7544–7554.
45. Perez-Juste, J.; Pastoriza-Santos, I.; Liz-Marzan, L. M.; Mulvaney, P. Gold nanorods: Synthesis, characterization and applications. Coordin. Chem. Rev. 2005, 249, 1870–1901.
46. Jiang, X. C.; Brioude, A.; Pileni, M. P. Gold nanorods: Limitations on their synthesis and optical properties. Colloid Surf. A-Physicochem. Eng. Asp. 2006, 277, 201–206.
47. Link, S.; Mohamed, M. B.; EI-Sayed, M. A. Simulation of the optical absorption spectra of gold nanorods as a function of their aspect ratio and the effect of the medium dielectric constant. J. Phys. Chem. B1999, 103, 3073–3077.
48. Liang, Z.; Li, X.; Xie, Y.; Liu, S. ‘Smart’gold nanoshells for combined cancer chemotherapy and hyperthermia. Biomed. Mater. 2014, 9, 025012.
49. Xia, Y.; Li, W.; Cobley, C. M.; Chen, J.; Xia, X.; Zhang, Q.; Yang, M.; Cho, E. C.; Brown, P. K. Gold nanocages: From synthesis to theranostic applications. Acc. Chem. Res. 2011, 44, 914–924.
50. Dreaden, E. C.; Mackey, M. A.; Huang, X.; Kang, B.; EI-Sayed, M. A. Beating cancer in multiple ways using nanogold. Chem. Soc. Rev. 2011, 40, 3391–3404.
51. Terentyuk, G.; Panfilova, E.; Khanadeev, V.; Chumakov, D.; Genina, E.; Bashkatov, A.; Tuchin, V.; Bucharskaya, A.; Maslyakova, G.; Khlebtsov, N. et al. Gold nanorods with a hematoporphyrin-loaded silica shell for dual-modality photodynamic and photothermal treatment of tumors in vivo. Nano Res. 2014, 7, 325–337.
52. Goettmann, F.; Moores, A.; Boissiere, C.; Le Floch, P.; Sanchez, C. A selective chemical sensor based on the plasmonic response of phosphinine-stabilized gold nanoparticles hosted on periodically organized mesoporous silica thin layers. Small2005, 1, 636–639.
53. Liz-Marzan, L. M.; Giersig, M.; Mulvaney, P. Synthesis of nanosized gold-silica core-shell particles. Langmuir1996, 12, 4329–4335.
54. Underwood, S.; Mulvaney, P. Effect of the solution refractive index on the color of gold colloids. Langmuir1994, 10, 3427–3430.
55. 2 particles. J. Phys. Chem. B2001, 105, 3441–3452.
56. Maye, M. M.; Lim, I. I.; Luo, J.; Rab, Z.; Rabinovich, D.; Liu, T.; Zhong, C. J. Mediator-template assembly of nanoparticles. J. Am. Chem. Soc. 2005, 127, 1519–1529.
57. Kumar, A.; Zhang, X.; Liang, X. J. Gold nanoparticles: Emerging paradigm for targeted drug delivery system. Biotechnol. Adv. 2013, 31, 593–606.
58. Rana, S.; Bajaj, A.; Mout, R.; Rotello, V. M. Monolayer coated gold nanoparticles for delivery applications. Adv. Drug Deliv. Rev. 2012, 64, 200–216.
59. Kumar, D.; Saini, N.; Jain, N.; Sareen, R.; Pandit, V. Gold nanoparticles: An era in bionanotechnology. Expert Opin. Drug Deliv. 2013, 10, 397–409.
60. Frens, G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature Phy. Sci. 1973, 241, 20–22.
61. Turkevich, J.; Stevenson, P. C.; Hillier, J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss. Faraday Soc. 1951, 11, 55–75.
62. Dumur, F.; Guerlin, A.; Dumas, E.; Bertin, D.; Gigmes, D.; Mayer, C. R. Controlled spontaneous generation of gold nanoparticles assisted by dual reducing and capping agents. Gold Bull. 2011, 44, 119–137.
63. Katti, K.; Chanda, N.; Shukla, R.; Zambre, A.; Suibramanian, T.; Kulkarni, R. R.; Kannan, R.; Katti, K. V. Green nanotechnology from cumin phytochemicals: Generation of biocompatible gold nanoparticles. Int. J. Green Nanotechol. Biomed. 2009, 1, B39–B52.
64. Ganeshkumar, M.; Ponrasu, T.; Raja, M. D.; Subamekala, M. K.; Suguna, L. Green synthesis of pullulan stabilized gold nanoparticles for cancer targeted drug delivery. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2014, 130, 64–71.
65. Iram. Y.; Igbal, M. S.; Athar, M. M.; Saeed, M. Z.; Yasmeen, A.; Ahmad, R. Glucoxylan-mediated green synthesis of gold and silver nanoparticles and their phyto-toxicity study. Carbohydr. Polym. 2014, 104, 29–33.
66. Menon, D.; Basanth, A.; Retnakumari, A.; Manzoor, K.; Nair, S. V. Green synthesis of biocompatible gold nanocrystals with tunable surface plasmon resonance using garlic phytochemicals. J. Biomed. Nanotechnol. 2012, 8, 901–911.
67. Mohan Kumar, K.; Mandal, B. K.; Kiran Kumar, H. A.; Maddinedi, S. B. Green synthesis of size controllable gold nanoparticles. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2013, 116, 539–545.
68. Correa-Llanten, D. N.; Muñoz-Ibacache, S. A.; Castro, M. E.; Munoz, P. A.; Blamey, J. M. Gold nanoparticles synthesized by geobacillus sp strain ID17 a thermophilic bacterium isolated from deception island, antarctica. Microb. Cell Fact. 2013, 12, 75.
69. Mittal, A. K.; Chisti, Y.; Banerjee, U. C. Synthesis of metallic nanoparticles using plant extracts. Biotechnol. Adv. 2013, 31, 346–356.
70. Rahme, K.; Nolan, M. T.; Doody, T.; McGlacken, G. P.; Morris, M. A.; O’Driscoll, C.; Holmes, J. D. Highly stable PEGylated gold nanoparticles in water: Applications in biology and catalysis. RSC Adv. 2013, 3, 21016–21024.
71. Guo, J.; Armstrong, M. J.; O’Driscoll, C. M.; Holmes, J. D.; Rahme, K. Positively charged, surfactant-free gold nanoparticles for nucleic acid delivery. RSC Adv. 2015, 5, 17862–17871.
72. Brust, M.; Walker, M.; Bethell, D.; Schiffrin, D. J.; Whyman, R. Synthesis of thiol-derivatised gold nanoparticles in a twophase liquid-liquid system. J. Chem. Soc., Chem. Commun. 1994, 801–802.
73. Sardar, R.; Funston, A. M.; Mulvaney, P.; Murray, R. W. Gold nanoparticles: Past, present, and future. Langmuir2009, 25, 13840–13851.
74. Lu, W.; Huang, Q.; Ku, G.; Wen, X.; Zhou, M.; Guzatov, D.; Brecht, P.; Su, R.; Oraevsky, A.; Wang, L.V. et al. Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres. Biomaterials2010, 31, 2617–2626.
75. Kim, D.; Jeong, Y. Y.; Jon, S. A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CTimaging and therapy of prostate cancer. ACS Nano2010, 4, 3689–3696.
76. Jain, N. K.; Nahar, M. PEGylated nanocarriers for systemic delivery. In Cancer Nanotechnology: Methods and Protocols; Grobmyer, S. R.; Moudgil, B. M., Eds.; Springer: New York, 2010; pp 221–234.
77. Amoozgar, Z.; Yeo, Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2012, 4, 219–233.
78. Santos-Martinez, M. J.; Rahme, K.; Corbalan, J. J.; Faulkner, C.; Holmes, J. D.; Tajber, L.; Medina, C.; Radomski, M. W. Pegylation increases platelet biocompatibility of gold nanoparticles. J. Biomed. Nanotechnol. 2014, 10, 1004–1015.
79. Pooja, D.; Panyaram, S.; Kulhari, H.; Rachamalla, S. S.; Sistla, R. Xanthan gum stabilized gold nanoparticles: Characterization, biocompatibility, stability and cytotoxicity. Carbohydr. Polym. 2014, 110, 1–9.
80. Latorre, A.; Posch, C.; Garcimartín, Y.; Celli, A.; Sanlorenzo, M.; Vujic, I.; Ma, J.; Zekhtser, M.; Rappersberger, K.; Ortiz-Urda, S. et al. DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics. Nanoscale2014, 6, 7436–7442.
81. Imperatore, R.; Carotenuto, G.; Di Grazia, M. A.; Ferrandino, I.; Palomba, L.; Mariotti, R.; Vitale, E.; De Nicola, S.; Longo, A.; Cristino, L. Imidazole-stabilized gold nanoparticles induce neuronal apoptosis: An in vitro and in vivo study. J. Biomed. Mater. Res. A2015, 103, 1436–1446.
82. Hinterwirth, H.; Lindner, W.; Lammerhofer, M. Bioconjugation of trypsin onto gold nanoparticles: Effect of surface chemistry on bioactivity. Anal. Chim. Acta2012, 733, 90–97.
83. Tao, W.; Ziemer, K. S.; Gill, H. S. Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus. Nanomedicine (Lond)2014, 9, 237–251.
84. Ling, D.; Hackett, M. J.; Hyeon, T. Surface ligands in synthesis, modification, assembly and biomedical applications of nanoparticles. Nano Today2014, 9, 457–477.
85. Zhang, Z.; Jia, J.; Lai, Y.; Ma, Y.; Weng, J.; Sun, L. Conjugating folic acid to gold nanoparticles through glutathione for targeting and detecting cancer cells. Bioorg. Med. Chem. 2010, 18, 5528–5534.
86. Choi, C. H.; Alabi, C. A.; Webster, P.; Davis, M. E. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc. Natl. Acad. Sci. USA2010, 107, 1235–1240.
87. Prades, R.; Guerrero, S.; Araya, E.; Molina, C.; Salas, E.; Zurita, E.; Selva, J.; Egea, G.; Lopez-Iglesias, C.; Teixido, M. et al. Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor. Biomaterials2012, 33, 7194–7205.
88. Chang, Y. C.; Yang, C. Y.; Sun, R. L.; Cheng, Y. F.; Kao, W. C.; Yang, P. C. Rapid single cell detection of staphylococcus aureus by aptamer-conjugated gold nanoparticles. Sci. Rep. 2013, 3, 1863.
89. Kumar, S.; Aaron, J.; Sokolov, K. Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. Nat. Protoc. 2008, 3, 314–420.
90. Shiao, Y. S.; Chiu, H. H.; Wu, P. H.; Huang, Y. F. Aptamerfunctionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery. ACS Appl. Matyer. Interfaces2014, 6, 21832–21841.
91. Arosio, D.; Chiodo, F.; Reina, J. J.; Marelli, M.; Penades, S.; van Kooyk, Y.; Garcia-Vallejo, J. J.; Bernardi, A. Effective targeting of DC-SIGN by a-fucosylamide functionalized gold nanoparticles. Bioconjug. Chem. 2014, 25, 2244–2251.
92. Choi, H. S.; Liu, W.; Liu, F.; Nasr, K.; Misra, P.; Bawendi, M. G.; Frangioni, J. V. Design considerations for tumour-targeted nanoparticles. Nat. Nanotechnol. 2010, 5, 42–47.
93. Rosi, N. L.; Giljohann, D. A.; Thaxton, C. S.; Lytton-Jean, A. K.; Han, M. S.; Mirkin, C. A. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science2006, 312, 1027–1030.
94. Conde, J.; Larguinho, M.; Cordeiro, A.; Raposo, L. R.; Costa, P. M.; Santos, S.; Diniz, M. S.; Fernandes, A. R.; Baptista, P. V. Gold-nanobeacons for gene therapy: Evaluation of genotoxicity, cell toxicity and proteome profiling analysis. Nanotoxicology2014, 8, 521–532.
95. Kim, J. H.; Yeom, J. H.; Ko, J. J.; Han, M. S.; Lee, K.; Na, S. Y.; Bae, J. Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles. J. Biotechnol. 2011, 155, 287–292.
96. Crew, E.; Tessel, M. A.; Rahman, S.; Razzak-Jaffar, A.; Mott, D.; Kamundi, M.; Yu, G.; Tchah, N.; Lee, J.; Bellavia, M. et al. MicroRNA conjugated gold nanoparticles and cell transfection. Anal. Chem. 2012, 84, 26–29.
97. Hao, L.; Patel, P. C.; Alhasan, A. H.; Giljohann, D. A.; Mirkin, C. A. Nucleic acid-gold nanoparticle conjugates as mimics of microRNA. Small2011, 7, 3158–3162.
98. Conde, J.; Rosa, J.; de la Fuente, J. M.; Baptisata, P. V. Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events. Biomaterials2013, 34, 2516–2523.
99. Kong, W. H.; Bae, K. H.; Hong, C. A.; Lee, Y.; Hahn, S. K.; Park, T. G. Multimerized siRNA cross-linked by gold nanoparticles. Bioconjug. Chem. 2011, 22, 1962–1969.
100. Giljohann, D. A.; Seferos, D. S.; Prigodich, A. E.; Patel, P. C.; Mirkin, C. A. Gene regulation with polyvalent siRNAnanoparticle conjugates. J. Am. Chem. Soc. 2009, 131, 2072–2073.
101. Lee, J. S.; Green, J. J.; Love, K. T.; Sunshine, J.; Langer, R.; Anderson, D. G. Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett. 2009, 9, 2402–2406.
102. Patel, P. C.; Hao, L.; Yeung, W. S.; Mirkin, C. A. Duplex end breathing determines serum stability and intracellular potency of siRNA-Au NPs. Mol. Pharm. 2011, 8, 1285–1291.
103. Son, S.; Nam, J.; Kim, J.; Kim, S.; Kim, W. J. i-motifdriven Au nanomachines in programmed siRNA delivery for gene-silencing and photothermal ablation. ACS Nano2014, 8, 5574–5584.
104. Jensen, S. A.; Day, E. S.; Ko, C. H.; Hurley, L. A.; Luciano, J. P.; Kouri, F. M.; Merkel, T. J.; Luthi, A. J.; Patel, P. C.; Cutler, J. I. et al. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci. Transl. Med. 2013, 5, 209ra152.
105. Zheng, D.; Giljohann, D. A.; Chen, D. L.; Massich, M. D.; Wang, X. Q.; Iordanov, H.; Mirkin, C. A.; Paller, A. S. Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc. Natl. Acad. Sci. USA2012, 109, 11975–11980.
106. Conde, J.; Tian, F.; Hernandez, Y.; Bao, C.; Cui, D.; Janssen, K. P.; Ibarra, M. R. Baptista, P. V.; Stoeger, T.; de la Fuente, J. M. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models. Biomaterials2013, 34, 7744–7753.
107. nd; Huang, Q.; Gelovani, J. G.; Li, C. Tumor site-specific silencing of NF-κB p65 by targeted hollow gold nanosphere-mediated photothermal transfection. Cancer Res. 2010, 70, 3177–3188.
108. Ghosh, R.; Singh, L. C.; Shohet, J. M.; Gunaratne, P. H. A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells. Biomaterials2013, 34, 807–816.
109. Song, W. J.; Du, J. Z.; Sun, T. M.; Zhang, P. Z.; Wang, J. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. Small2010, 6, 239–246.
110. Huang, S.; Deshmukh, H.; Rajagopalan, K. K.; Wang, S. Gold nanoparticles electroporation enhanced polyplex delivery to mammalian cells. Electrophoresis2014, 35, 1837–1845.
111. Lee, Y.; Lee, S. H.; Kim, J. S.; Maruyama, A.; Chen, X.; Park, T. G. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery. J. Control. Release2011, 155, 3–10.
112. Kong, W. H.; Bae, K. H.; Jo, S. D.; Kim, J. S.; Park, T. G. Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehicles. Pharm. Res. 2012, 29, 362–374.
113. Lee, S. H.; Bae, K. H.; Kim, S. H.; Lee, K. R.; Park, T. G. Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers. Int. J. Pharm. 2008, 364, 94–101.
114. Kim, S. T.; Chompoosor, A.; Yeh, Y. C.; Agasti, S. S.; Solfiell, D. J.; Rotello, V. M. Dendronized gold nanoparticles for siRNA delivery. Small2012, 8, 3253–3256.
115. Mitra, M.; Kandalam, M.; Rangasamy, J.; Shankar, B.; Maheswari, U. K.; Swaminathan, S.; Krishnakumar, S. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells. Mol. Vis. 2013, 19, 1029–1038.
116. Zhao, E.; Zhao, Z.; Wang, J.; Yang, C.; Chen, C.; Gao, L.; Feng, Q.; Hou, W.; Gao, M.; Zhang, Q. Surface engineering of gold nanoparticles for in vitro siRNA delivery. Nanoscale2012, 4, 5102–5109.
117. Guo, S.; Huang, Y.; Jiang, Q.; Sun, Y.; Deng, L.; Liang, Z.; Du, Q.; Xing, J.; Zhao, Y.; Wang, P. C. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano2010, 4, 5505–5511.
118. Lee, S. K.; Han, M. S.; Asokan, S.; Tung, C. H. Effective gene silencing by multilayered siRNA-coated gold nanoparticles. Small2011, 7, 364–370.
119. Han, L.; Zhao, J.; Zhang, X.; Cao, W.; Hu, X.; Zou, G.; Duan, X.; Liang, X. J. Enhanced siRNA delivery and silencing gold–chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility. ACS Nano2012, 6, 7340–7351.
120. Elbakry, A.; Zaky, A.; Liebl, R.; Rachel, R.; Goepferich, A.; Breunig, M. Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett. 2009, 9, 2059–2064.
121. Bonoiu, A. C.; Mahajan, S. D.; Ding, H.; Roy, I.; Yong, K. T.; Kumar, R.; Hu, R.; Bergey, E. J.; Schwartz, S. A.; Prasad, P. N. Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons. Proc. Natl. Acad. Sci. USA2009, 106, 5546–5550.
122. Bonoiu, A. C.; Bergey, E. J.; Ding, H.; Hu, R.; Kumar, R.; Yong, K. T.; Prasad, P. N.; Mahajan, S.; Picchione, K. E.; Bhattacharjee, A. et al. Gold nanorod-siRNA induces efficient in vivo gene silencing in the rat hippocampus. Nanomedicine (Lond)2011, 6, 617–630.
123. Lee, M. Y.; Park, S. J.; Park, K.; Kim, K. S.; Lee, H.; Hahn, S. K. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. ACS Nano2011, 5, 6138–6147.
124. Bishop, C. J.; Tzeng, S. Y.; Green, J. J. Degradable polymercoated gold nanoparticles for co-delivery of DNA and siRNA. Acta Biomater. 2015, 11, 393–403.
125. Yan, Y.; Bjornmalm, M.; Caruso, F. Assembly of layer-bylayer particles and their interactions with biological systems. Chem. Mater. 2014, 26, 452–460.
126. Mintzer, M. A.; Simanek, E. E. Nonviral vectors for gene delivery. Chem. Rev. 2009, 109, 259–302.
127. Zhang, Y.; Wang, Z.; Gemeinhart, R. A. Progress in microRNA delivery. J. Control. Release2013, 172, 962–974.
128. Guo, J.; Evans, J. C.; O’Driscoll, C. M. Delivering RNAi therapeutics with non-viral technology: A promising strategy for prostate cancer? Trends Mol. Med. 2013, 19, 250–261.
129. Wilson, R. C.; Doudna, J. A. Molecular mechanisms of RNA interference. Annu. Rev. Biophys. 2013, 42, 217–239.
130. Fellmann, C.; Lowe, S. W. Stable RNA interference rules for silencing. Nat. Cell Biol. 2014, 16, 10–18.
131. Guo, J.; Fisher, K. A.; Darcy, R.; Cryan, J. F.; O’ Driscoll, C. Therapeutic targeting in the silent era: Advances in nonviral siRNA delivery. Mol. Biosyst. 2010, 6, 1143–1161.
132. Chan, E.; Prado, D. E.; Weidhaas, J. B. Cancer microRNAs: From subtype profiling to predictors of response to therapy. Trends Mol. Med. 2011, 17, 235–243.
133. Leal, J. A.; Feliciano, A.; Lleonart, M. E. Stem cell microRNAs in senescence and immortalization: Novel players in cancer therapy. Med. Res. Rev. 2013, 33, 112–138.
134. Momi, N.; Kaur, S.; Rachagani, S.; Ganti, A. K.; Batra, S. K. Smoking and microRNA dysregulation: A cancerous combination. Trends Mol. Med. 2014, 20, 36–47.
135. Haasnoot, J.; Westerhout, E. M.; Berkhout, B. RNA interference against viruses: Strike and counterstrike. Nat. Biotechnol. 2007, 25, 1435–1443.
136. Lu, P. Y.; Xie, F. Y.; Woodle, M. C. Modulation of angiogenesis with siRNA inhibitors for novel therapeutics. Trends Mol. Med. 2005, 11, 104–113.
137. Fitzgerald, K. A.; Evans, J. C.; McCarthy, J.; Guo, J.; Prenciple, M.; Kearney, M.; Watson, W. R.; O’ Driscoll C. M. The role of transcription factors in prostate cancer and potential for future RNA interference therapy. Expert Opin. Ther. Thargets2014, 18, 633–649.
138. Bennink, J. R.; Palmore, T. N. The promise of siRNAs for the treatment of influenza. Trends Mol. Med. 2004, 10, 571–574.
139. Whitehead, K. A.; Langer, R.; Anderson, D. G. Knocking down barriers: Advances in siRNA delivery. Nat. Rev. Drug Discov. 2009, 8, 129–138.
140. Cole, L. E.; Vargo-Gogola, T.; Roeder, R. K. Contrastenhanced X-ray detection of breast microcalcifications in a murine model using targeted gold nanoparticles. ACS Nano2014, 8, 7486–7496.
141. Chong, R. H.; Gonzalez-Gonzalez, E.; Lara, M. F.; Speaker, T. J.; Contag, C. H.; Kaspar, R. L.; Coulman, S. A.; Hargest, R.; Birchall, J. C. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept. J. Control. Release2013, 166, 211–219.
142. Burgess, A.; Hynynen, K. Noninvasive and targeted drug delivery to the brain using focused ultrasound. ACS Chem. Neurosci. 2013, 4, 519–526.
143. Wang, Y. H.; Chen, S. P.; Liao, A. H.; Yang, Y. C.; Lee, C. R; Wu, C. H.; Wu, P. C.; Liu, T. M.; Wang, C. R.; Li, P. C. Synergistic delivery of gold nanorods using multifunctional microbubbles for enhanced plasmonic photothermal therapy. Sci. Rep. 2014, 4, 5685.
144. Wegscheid, M. L.; Morshed, R. A.; Cheng, Y.; Lesniak, M. S. The art of attraction: Applications of multifunctional magnetic nanomaterials for malignant glioma. Expert Opin. Drug Deliv. 2014, 11, 957–975.
145. Hyodo, M.; Sakurai, Y.; Akita, H.; Harashima, H. “Programmed packaging” for gene delivery. J. Control. Release2014, 193, 316–323.
146. Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Bombelli, F. B.; Dawson, K. A. Physical-chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133, 2525–2534.
147. Salvati, A.; Pitek, A. S.; Monopoli, M. P.; Prapainop, K.; Bombelli, F. B.; Hristov, D. R.; Kelly, P. M.; Aberg, C.; Mahon, E.; Dawson, K. A. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 2013, 8, 137–143.
148. de Wolf, H. K.; Snel, C. J.; Verbaan, F. J.; Schiffelers, R. M.; Hennink, W. E.; Storm, G. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration. Int. J. Pharm. 2007, 331, 167–175.
149. Cao-Milan, R.; Liz-Marzan, L. M. Gold nanoparticle conjugates: Recent advances toward clinical applications. Expert Opin. Drug Deliv. 2014, 11, 741–752.
150. Iosin, M.; Toderas, F.; Baldeck, P. L.; Astilean, S. Study of protein-gold nanoparticle conjugates by fluorescence and surface-enhanced Raman scattering. J. Mol. Struct. 2009, 924–926, 196–200.
151. Pan, B.; Cui, D.; Xu, P.; Li, Q.; Huang, T.; He, R.; Gao, F. Study on interaction between gold nanorod and bovine serum albumin. Colloid Surf. A-Physicochem. Eng. Asp. 2007, 295, 217–222.
152. Brewer, S. H.; Glomm, W. R.; Johnson, M. C.; Knag, M. K.; Franzen, S. Probing BSA binding to citrate-coated gold nanoparticles and surfaces. Langmuir2005, 21, 9303–9307.
153. Alkilany, A. M.; Thompson, L. B.; Boulos, S. P.; Sisco, P. N.; Murphy, C. J. Gold nanorods: Their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv. Drug Deliv. Rev. 2012, 64, 190–199.
154. Jokerst, J. V.; Lobovkina, T.; Zare, R. N.; Gambhir, S. S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond)2011, 6, 715–728.
155. Guo, J.; Ogier, J. R.; Desgranges, S.; Darcy, R.; O’Driscoll, C. Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice. Biomaterials2012, 33, 7775–7784.
156. Gao, J.; Chen, H.; Yu, Y.; Song, J.; Song, H.; Su, X.; Li, W.; Tong, X.; Qian, W.; Wang, H. et al. Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA. Biomaterials2013, 34, 10084–10098.
157. Leus, N. G.; Morselt, H. W.; Zwiers, P. J.; Kowalski, P. S.; Ruiters, M. H.; Molema, G.; Kamps, J. A. VCAM-1 specific PEGylated SAINT-based lipoplexes deliver siRNA to activated endothelium in vivo but do not attenuate target gene expression. Int. J. Pharm. 2014, 469, 121–131.
158. Koide, H.; Asai, T.; Hatanaka, K.; Akai, S.; Ishii, T.; Kenjo, E.; Ishida, T.; Kiwada, H.; Tsukada, H.; Oku, N. T cellindependent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes. Int. J. Pharm. 2010, 392, 218–223.
159. Schellekens, H.; Hennink, W. E.; Brinks, V. The immunogenicity of polyethylene glycol: Facts and fiction. Pharm. Res. 2013, 30, 1729–1734.
160. He, Z.; Liu, J.; Du, L. The unexpected effect of PEGylated gold nanoparticles on the primary function of erythrocytes. Nanoscale2014, 6, 9017–9024.
161. Moghimi, S. M.; Hunter, A. C.; Andresen, T. L. Factors controlling nanoparticle pharmacokinetics: An integrated analysis and perspective. Annu. Rev. Pharmacol. Toxicol. 2012, 52, 481–503.
162. Quail, D. F.; Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 2013, 19, 1423–1437.
163. Chithrani, B. D.; Ghazani, A. A.; Chan, W. C. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006, 6, 662–668.
164. Suresh, D.; Zambre, A.; Chanda, N.; Hoffman, T. J.; Smith, C. J.; Robertson, J. D.; Kannan, R. Bombesin peptide conjugated gold nanocages internalize via clathrin mediated endocytosis. Bioconjug. Chem. 2014, 25, 1565–1579.
165. Junttila, M. R.; de Sauvage, F. J. Influence of tumour microenvironment heterogeneity on therapeutic response. Nature2013, 501, 346–354.
166. Egeblad, M.; Nakasone, E. S.; Werb, Z. Tumors as organs: Complex tissues that interface with the entire organism. Dev. Cell2010, 18, 884–901.
167. Ruan, S.; Yuan, M.; Zhang, L.; Hu, G.; Chen, J.; Cun, X.; Zhang, Q.; Yang, Y.; He, Q.; Gao H. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles. Biomaterials2015, 37, 425–435.
168. O’Mahony, A. M.; Godinho, B. M.; Cryan, J. F.; O’Driscoll, C. M. Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: Formulating the solution. J. Pharm. Sci. 2013, 102, 3469–3484.
169. Chen, Y.; Liu, L. Modern methods for delivery of drugs across the blood-brain barrier. Adv. Drug Deliv Rev. 2012, 64, 640–665.
170. Huang, R.; Ke, W.; Liu, Y.; Jiang, C.; Pei, Y. The use of lactoferrin as a ligand for targeting the polyamidoaminebased gene delivery system to the brain. Biomaterials2008, 29, 238–246.
171. Kumar, P.; Wu, H.; McBride, J. L.; Jung, K. E.; Kim, M. H.; Davidson, B. L.; Lee, S. K.; Shankar, P.; Manjunath, N. Transvascular delivery of small interfering RNA to the central nervous system. Nature2007, 448, 39–43.
172. Chacko, A. M.; Li, C.; Pryma, D. A.; Brem, S.; Coukos, G.; Muzykantov, V. Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: Crossing the blood-brain barrier divide. Expert Opin. Drug Deliv. 2013, 10, 907–926.
173. Allen, T. M. Ligand-targeted therapeutics in anticancer therapy. Nat. Rev. Cancer2002, 2, 750–763.
174. Wang, F.; Shen, Y.; Zhang, W.; Li, M.; Wang, Y.; Zhou, D.; Guo, S. Efficient, dual-stimuli responsive cytosolic gene delivery using a RGD modified disulfide-linked polyethylenimine functionalized gold nanorod. J. Control. Release2014, 196, 37–51.
175. Sakurai, Y.; Hatakeyama, H.; Sato, Y.; Akita, H.; Takayama, K.; Kobayashi, S.; Futaki, S.; Harashima, H. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA. Biomaterials2011, 32, 5733–5742.
176. Guo, J.; Cheng, W. P.; Gu, J.; Ding, C.; Qu, X.; Yang, Z.; O’Driscoll, C. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly- L-lysine nanocarrier to suppress prostate cancer growth in mice. Eur. J. Pharm. Sci. 2012, 45, 521–532.
177. Kwon, Y. J. Before and after endosomal escape: Roles of stimuli-converting siRNA/polymer interactions in determining gene silencing efficiency. Acc. Chem. Res. 2012, 45, 1077–1088.
178. Koren, E.; Torchilin, V. P. Cell-penetrating peptides: Breaking through to the other side. Trends Mol. Med. 2012, 18, 385–393.
179. Knight, M. W.; Sobhani, H.; Nordlander, P.; Halas, N. J. Photodetection with active optical antennas. Science2011, 332, 702–704.
180. Schmidt, B.; Loeschner, K.; Hadrup, N.; Mortensen, A.; Sloth, J. J.; Koch, C. B.; Larsen, E. H. Quantitative characterization of gold nanoparticles by field-flow fractionation coupled online with light scattering detection and inductively coupled plasma mass spectrometry. Anal. Chem. 2011, 83, 2461–2468.
181. Fratoddi, I.; Venditti, I.; Cametti, C.; Russo, M. V. How toxic are gold nanoparticles? The State-of-the-Art. Nano Res. 2015, 8, 1771–1799.
182. Xue, H. Y.; Liu, S.; Wong, H. L. Nanotoxicity: A key obstacle to clinical translation of siRNA-based nanomedicine. Nanomedicine (Lond)2014, 9, 295–312.
183. Zhang, X. D.; Wu, D.; Shen, X.; Liu, P. X.; Yang, N.; Zhao, B.; Zhang, H.; Sun, Y. M.; Zhang, L. A.; Fan, F. Y. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int. J. Nanomedicine2011, 6, 2071–2081.
184. Sun, Y. N.; Wang, C. D.; Zhang, X. M.; Ren, L.; Tian, X. H. Shape dependence of gold nanoparticles on in vivo acute toxicological effects and biodistribution. J. Nanosci. Nanotechnol. 2011, 11, 1210–1216.
185. Thakor, A. S.; Luong, R.; Paulmurugan, R.; Lin, F. I.; Kempen, P.; Zavaleta, C.; Chu, P.; Massoud, T. F.; Sinclair, R.; Gambhir, S. S. The fate and toxicity of Raman-active silica-gold nanoparticles in mice. Sci. Transl. Med. 2011, 3, 79ra33.
186. Simpson, C. A.; Salleng, K. J.; Cliffel, D. E.; Feldheim, D. L. In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. Nanomedicine2013, 9, 257–263.
187. Zhang, X. D.; Wu, H. Y.; Wu, D.; Wang, Y. Y.; Chang, J. H.; Zhai, Z. B.; Meng, A. M. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int. J. Nanomedicine2010, 5, 771–781.
188. Abdelhalim, M. A.; Jarrar, B. M. Gold nanoparticles induced cloudy swelling to hydropic degeneration, cytoplasmic hyaline vacuolation, polymorphism, binucleation, karyopyknosis, karyolysis, karyorrhexis and necrosis in the liver. Lipids Health Dis. 2011, 10, 166.
189. Chen, H.; Dorrigan, A.; Saad, S.; Hare, D. J.; Cortie, M. B.; Valenzuela, S. M. In vivo study of spherical gold nanoparticles: Inflammatory effects and distribution in mice. PLoS One2013, 8, e58208.
190. You, J.; Zhou, J.; Zhou, M.; Liu, Y.; Robertson, J. D.; Liang, D.; Van Pelt, C.; Li, C. Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres. Part. Fibre. Toxicol. 2014, 11, 26.
191. Abdelhalim, M. A.; Jarrar, B. M. The appearance of renal cells cytoplasmic degeneration and nuclear destruction might be an indication of GNPs toxicity. Lipids Health Dis. 2011, 10, 147.
192. Liu, X.; Huang, N.; Wang, H.; Li, H.; Jin, Q.; Ji, J. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles. Biomaterials2013, 34, 8370–8381.
193. Chen, J.; Wang, H.; Long, W.; Shen, X.; Wu, D.; Song, S. S.; Sun, Y. M.; Liu, P. X.; Fan, S.; Fan, F. et al. Sex differences in the toxicity of polyethylene glycol-coated gold nanoparticles in mice. Int. J. Nanomedicine2013, 8, 2409–2419.
194. Zhang, X. D.; Wu, D.; Shen, X.; Liu, P. X.; Fan, F. Y.; Fan, S. J. In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials2012, 33, 4628–4638.
195. Zhang, X. D.; Wu, D.; Shen, X.; Chen, J.; Sun, Y. M.; Liu, P. X.; Liang, X. J. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials2012, 33, 6408–6419.
196. De Jong, W. H.; Hagens, W. I.; Krystek, P.; Burger, M. C.; Sips, A. J.; Geertsma, R. E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials2008, 29, 1912–1919.
197. Keck, C. M.; Muller, R. H. Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems. Eur. J. Pharm. Biopharm. 2013, 84, 445–448.
198. Mussen, F.; Salek, S.; Walker, S. A quantitative approach to benefit-risk assessment of medicines—part 1: The development of a new model using multi-criteria decision analysis; part 2: The practical application of a new model. Pharmacoepidemiol. Drug Saf. 2007, Suppl 1, S42–S46.
199. Kostarelos, K.; Miller, A. D. Synthetic, self-assembly ABCD nanoparticles: A structural paradigm for viable synthetic non-viral vectors. Chem. Soc. Rev. 2005, 34, 970–994.